Human metapneumovirus (HMPV), a lesser-known virus, is responsible for a respiratory illness that usually presents symptoms similar to a common cold.
It is likely unfamiliar to the majority of individuals.
What is HPMV?
Discovered in 2001, human metapneumovirus belongs to the paramyxovirus family, which includes well-known viruses like parainfluenza, respiratory syncytial virus (RSV), measles, and mumps.
Typically, it leads to a common cold, which is generally not a significant concern for most people, according to infectious disease expert Monica Gandhi from the University of California at San Francisco.
What are the symptoms of HPMV?
Discovered in 2001, human metapneumovirus belongs to the paramyxovirus family, which includes well-known viruses like parainfluenza, respiratory syncytial virus (RSV), measles, and mumps.
Typically, it leads to a common cold, which is generally not a significant concern for most people, according to infectious disease expert Monica Gandhi from the University of California at San Francisco.
What’s the Buzz Surrounding Metapneumovirus?
Similar to other respiratory diseases, instances of human metapneumovirus have been increasing.
The Centers for Disease Control and Prevention recently noted significant spikes in cases during the spring across the United States.
Experts in virology have proposed that the rise in various viruses, including RSV, could be a consequence of COVID-19 lockdowns and mask-wearing.
Limited exposure to viruses weakens our immune system’s ability to combat multiple viral infections simultaneously.
As a result of years of mask usage and social distancing in schools, children have fewer natural defenses against multiple viruses.
How does HPMV spread?
Human metapneumovirus spreads in a similar manner to other viruses.
The CDC states that it can be transmitted through airborne particles released by coughing or sneezing, physical contact with an infected individual, or by touching contaminated surfaces and then touching the eyes, mouth, or nose.
It is important to understand that the virus can be transmitted even when individuals do not show any symptoms.
According to a study, asymptomatic cases accounted for at least 38 percent of human metapneumovirus infections.
However, it should be noted that the highest risk of spreading the virus occurs when active symptoms are present.
As explained by Gandhi, during this period, infected individuals release the virus through coughing and sneezing, making it highly contagious.
How is HMPV treated?
Human metapneumovirus (HMPV) is a respiratory virus that has been known to exist for many years.
Unlike the novel coronavirus (SARS-CoV-2) and its variants that cause COVID-19, there is currently no specific vaccine available for HMPV.
The treatment for HMPV is primarily supportive care, aimed at alleviating symptoms and ensuring adequate breathing while the body fights off the virus.
Most people infected with HMPV fully recover on their own.
In severe cases of HMPV where individuals experience difficulty breathing, they may require intensive care unit (ICU) treatment.
However, such cases are rare, and the majority of people with HMPV recover without the need for intensive medical intervention.
It’s important to note that HMPV is not expected to cause a pandemic like COVID-19.
It is a well-known respiratory virus that has been circulating among human populations for a long time.
While advances in the understanding and management of HMPV are anticipated in the future, at present, supportive care remains the primary approach to its treatment.
ALSO READ: Nikki Catsouras Death Photographs: The Haunting Images
ncG1vNJzZmibnq6urMHNnaBnm5%2BifKnBzJqlZqWVqa6xusSupKiumafCtHnHpqevZw%3D%3D